Search for: "Astrazeneca" Results 941 - 960 of 1,246
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jan 2022, 8:35 am by Lisa Larrimore Ouellette
Most of these studies involve the AstraZeneca vaccine that has not yet been authorized in the United States, and while a few describe the benefits of boosting J&J recipients with mRNA vaccines (like the COV-BOOST and SWITCH trials), the EMA emphasizes that there is “limited data on interchangeability of mRNA vaccines. [read post]
5 Aug 2020, 11:43 am by Lisa Larrimore Ouellette
Italy, Germany, France, and the Netherlands set up the Inclusive Vaccines Alliance—which other EU countries may join—and signed a €750M contract for 400M doses of the AstraZeneca-Oxford vaccine. [read post]
3 Feb 2021, 9:30 pm by Brett Holubeck
A Catholic may receive the AstraZeneca vaccine if no other vaccine is available. [read post]
14 Dec 2022, 1:23 pm by Kevin LaCroix
Nevertheless, the extent to which the dismissal motions that have been ruled upon have been granted is noteworthy — dismissal motions have been granted in a number of COVID-19 related cases, including, for example, the cases pending against the cruise ship lines (as discussed, for example, here); as well as in cases filed against, among others, AstraZeneca (here); Sorrento Therapeutics (here); The Geo Group (here); and Velocity Financial (here). [read post]
3 Oct 2011, 8:01 pm by FDABlog HPM
  According to AZ: FDA has periodically required AstraZeneca to revise its label to include new information concerning the use of Seroquel. [read post]
8 Feb 2021, 9:16 am by Matthieu Dhenne (Ipsilon)
Readers of the Blog should remember the French landmark French judgment rendered in September 2020 in the European Pemetrexed saga, which condemned Fresenius to pay € 28 million in damages (see here). [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
Plaintiffs allege, among other things, that AstraZeneca violated Sections 1 and 2 of the Sherman Act (15 U.S.C. [read post]
17 Jan 2008, 10:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:The European antitrust raids on Pfizer, AstraZeneca, Glaxo, Sanofi-Aventis: (IP Law360), (Wall Street Journal Health Blog), (IAM), (IPEG), (SmartBrief), (In the pipeline),Hasbro and Mattel alleged trade mark infringement and demand shut down of Scrabulous, a free online gaming site allowing users to play a version of… [read post]
17 Sep 2020, 9:05 pm by Max Masuda-Farkas
AstraZeneca has remained tight lipped about the participant’s illness while emphasizing its commitment to industry and regulatory safety standards. [read post]
23 Jul 2009, 3:15 am
Astrazeneca Pharmaceuticals LP), because of Bexis' firm's involvement in the litigation (although not this aspect). [read post]
15 Mar 2016, 7:35 am
Till date, there’s no Central law mandating disclosure of data on patients, treatment methods, drug pricing, etc.Interestingly, the same data deficit was used by the government to deny the most recent compulsory licensing application under Section 84 to Lee Pharma, which bid for a licence against AstraZeneca’s Saxagliptin, a patented anti-diabetic drug. [read post]
14 Mar 2023, 4:09 pm by Yogeeta B. Jadhav and Fatih Mercan
Kimberly Braslow, Patent Director, AstraZeneca, and Vice Chair, AIPLA Food and Drug Committee. [read post]
21 Jul 2020, 3:08 pm by Matt Gluck
All three developers — British-Swedish pharmaceutical company AstraZeneca, Chinese firm CanSino Biologics and a collaboration between American pharmaceutical giant Pfizer and German company BioNTech — said individuals inoculated with their vaccines showed similar antibody levels to those who have recovered from COVID-19. [read post]
21 Jan 2015, 3:02 pm
Brilinta’s manufacturer, AstraZeneca, tabbed it for special promotion attention, noting that doctors are “indispensable partners in our efforts to bring new medicines to patients. [read post]
9 May 2021, 4:35 am by Keith Mallinson
With competition among many different clinically approved vaccine technologies and suppliers including the highly effective, safe and easy to distribute Oxford/AstraZeneca vaccine priced at around $5 per dose already, existing free market commercial pressures on licensing charges—including patent royalties and for transfers of other intellectual property—are substantial. [read post]
26 Aug 2022, 7:25 am by Florian Mueller
A "sore loser" narrative wouldn't work in this context.I'm a "mix-and-match" vaccinee: I started with AstraZeneca's vaccine, followed by BioNTech's Comirnaty (which was the plan from the beginning), and in January I got a Moderna booster. [read post]
21 Jul 2017, 3:14 am
. | Changes to the Singapore copyright system: an update on the recent public consultations | he diplomatic crisis of Qatar and Gulf Cooperation Council's IP | Bundesgerichtshof's landmark ruling to hook extra-territorial patent infringement in Germany | BREAKING: Eli Lilly success as UK Supreme Court finds Actavis products directly and indirectly infringe pemetrexed patent | Monday Miscellany | Sunday SurprisesNever Too Late 154 [week ending Sunday 2 July] I Book Review: Patent… [read post]